Abstract
The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. The 2017 meeting was held from September 25–27 in Melbourne, Australia, and was hosted by the Peter Doherty Institute for Infection and Immunity and the Institut Pasteur. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including the recent Zika epidemic, infections by human papillomavirus, influenza, HIV, hepatitis C, HTLV-1, and chikungunya viruses, and new and emerging viruses in the Australasia region. Plans for the 2018 meeting also are noted.
The GVN is an international research network comprised of 40 Centers of Excellence and 6 Affiliates in 24 countries.
The 2017 Global Virus Network (GVN) Meeting was held in Melbourne, Australia from September 25–27.
New data were presented on various aspects of medical virology, therapies, and emerging viruses in the Australasia region.
International collaboration is critical to developing new and effective viral vaccines and therapeutics.
The 2018 international GVN meeting will be held on November 28–30 in Annecy, France.
Collapse